- This event has passed.
Biomarker-driven Drug Development for Allergic Diseases and Asthma – Public Workshop
February 22
The Food and Drug Administration (FDA) is announcing a 1-day public workshop, regarding development and use of biomarkers in the regulation of allergenics to treat respiratory and food allergies.
This public workshop is intended to be a forum for the exchange of information and perspectives among regulators and academic investigators on the use of biomarkers to monitor, predict efficacy, and evaluate responses to novel therapeutics for allergic diseases. The input from this public workshop will facilitate decisions by regulatory agencies, industry, and clinical investigators on the use of biomarkers in clinical trials for allergenics, biologics and drugs used to treat respiratory allergic disease and food allergy in children and adults.
Click the link below to register.
